113
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Nose-to-brain delivery of TS-002, prostaglandin D2 analogue

, , &
Pages 59-66 | Received 08 Aug 2006, Accepted 22 Sep 2006, Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

R. Jayachandra Babu, Pankaj Patrick Dayal, Kasturi Pawar & Mandip Singh. (2011) Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats. Journal of Drug Targeting 19:9, pages 731-740.
Read now
Sandra R. Alcalá-Barraza, Michael S. Lee, Leah R. Hanson, Abby A. McDonald, William H. Frey$suffix/text()$suffix/text() & Linda K. McLoon. (2010) Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. Journal of Drug Targeting 18:3, pages 179-190.
Read now
Hongbing Wu, Kaili Hu & Xinguo Jiang. (2008) From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opinion on Drug Delivery 5:10, pages 1159-1168.
Read now

Articles from other publishers (12)

Thelma Akanchise & Angelina Angelova. (2023) Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy. Pharmaceutics 15:5, pages 1562.
Crossref
Sachin S. Gaikwad, Snehal R. Pathare, Mayur A. More, Nikita A. Waykhinde, Umesh D. Laddha, Kishor S. Salunkhe, Sanjay J. Kshirsagar, Sakshi S. Patil & Kuldeep H. Ramteke. (2023) Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies. Journal of Controlled Release 355, pages 292-311.
Crossref
Chandrakantsing V. Pardeshi & Eliana B. Souto. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 93 114 .
Toshiyasu Sakane, Sachi Okabayashi, Shunsuke Kimura, Daisuke Inoue, Akiko Tanaka & Tomoyuki Furubayashi. (2020) Brain and Nasal Cavity Anatomy of the Cynomolgus Monkey: Species Differences from the Viewpoint of Direct Delivery from the Nose to the Brain. Pharmaceutics 12:12, pages 1227.
Crossref
Shinji Iwasaki, Syunsuke Yamamoto, Noriyasu Sano, Kimio Tohyama, Yohei Kosugi, Atsutoshi Furuta, Teruki Hamada, Tomoko Igari, Yasushi Fujioka, Hideki Hirabayashi & Nobuyuki Amano. (2019) Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys. Pharmaceutical Research 36:5.
Crossref
Fabio Sonvico, Adryana Clementino, Francesca Buttini, Gaia Colombo, Silvia Pescina, Silvia Stanisçuaski Guterres, Adriana Raffin Pohlmann & Sara Nicoli. (2018) Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting. Pharmaceutics 10:1, pages 34.
Crossref
Carla M. Lema Tomé, Trevor Tyson, Nolwen L. Rey, Stefan Grathwohl, Markus Britschgi & Patrik Brundin. (2012) Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?. Molecular Neurobiology 47:2, pages 561-574.
Crossref
Donald J. AbrahamAdrian Hall, Simon Peace & Martin E. Swarbrick. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 791 944 .
Shyeilla V. Dhuria, Leah R. Hanson & William H. FreyIIII. (2009) Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system. Journal of Pharmaceutical Sciences 98:7, pages 2501-2515.
Crossref
Elena Loseva, Ti-Fei Yuan & Sergei Karnup. (2009) Neurogliogenesis in the mature olfactory system: A possible protective role against infection and toxic dust. Brain Research Reviews 59:2, pages 374-387.
Crossref
Cathy A. Payne, Sanaz Maleki, Marinella Messina, Maree G. O'Sullivan, Glenn Stone, Nathan R. Hall, Jonathon F. Parkinson, Helen R. Wheeler, Raymond J. Cook, Michael T. Biggs, Nicholas S. Little, Charles Teo, Bruce G. Robinson & Kerrie L. McDonald. (2008) Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma. Molecular Cancer Therapeutics 7:10, pages 3420-3428.
Crossref
Stephen Allen. (2008) Are Inhaled Systemic Therapies a Viable Option for the Treatment of the Elderly Patient?. Drugs & Aging 25:2, pages 89-94.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.